VERU Veru Inc
- 1.490
- +0.140+10.37%
- 1.500
- +0.010+0.65%
Veru Inc News
Veru to Present at the GLP-1 Based Therapeutics Summit
MIAMI, FL, May 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss,
Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024
MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss,
Express News | Veru Enrolls First Patients In Phase 2b Clinical Trial Of Enobosarm And Semaglutide Combination For Weight Loss
Express News | Veru Inc: Topline Clinical Data Expected in Q4 Calendar Year 2024
Express News | Veru Enrolls First Patients in Phase 2B Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss
Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11
MIAMI, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high qual
Express News | Veru Inc: On April 23, Received Notification Letter From Nasdaq Confirming That Co Regained Compliance
Express News | Millennium Management LLC Reports 5.2% Passive Stake in Veru Inc as of April 18 - SEC Filing
LI, VERU and MRIN Among Pre-market Losers
Veru, EyePoint Pharmaceuticals, SINTX Technologies Among Healthcare Movers
Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d
Express News | Veru : Oppenheimer Cuts Target Price to $5 From $7
Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Farg
Express News | Oppenheimer Reiterates Outperform on Veru, Lowers Price Target to $5
Veru, Theravance Biopharma, Adial Pharmaceuticals Among Healthcare Movers
NKTR, VERU and EGIO Among Mid-day Movers
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
GainersFarmer Bros (NASDAQ:FARM) stock increased by 4.8% to $3.48 during Tuesday's after-market session. The company's market cap stands at $73.3 million. Pricesmart (NASDAQ:PSMT) stock moved upwards
Veru Announces Date of 2024 Annual Meeting of Shareholders
--2023 Form 10-K/A and Q1 2024 Form 10-Q filed today-- --2024 Annual Meeting of Shareholders will be June 18, 2024 -- MIAMI, FL, April 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late c
Express News | Veru Shares Are Trading Higher After Raymond James Initiated Coverage on the Stock With an Outperform Rating and a Price Target of $3
Veru Initiated at Outperform by Raymond James
Veru Initiated at Outperform by Raymond James
Analysis
Price Target
No Data
